Note: This column describes the author’s own experiences with a stem cell transplant. Not everyone will have the same response to treatment. Consult your doctor…

Enrollment is now complete for an early clinical study assessing the safety and tolerability of SENTI-202, Senti Biosciences’ cell therapy candidate for adults with…

The U.S. Food and Drug Administration (FDA) has approved Novocure’s Optune Pax, a type of Tumor Treating Fields (TTFields) therapy, as a treatment for…